動物微生物組市場規模、佔有率和成長分析：按動物種類、產品類型、原料、形態、應用、最終用戶、通路和地區分類——2026-2033年行業預測

2024年全球動物微生物組市場價值為43億美元，預計將從2025年的46.9億美元成長到2033年的94.2億美元。預測期（2026-2033年）的複合年成長率預計為9.1%。

全球動物微生物組市場專注於分析和調控家畜、水產養殖物種和伴侶動物體內的微生物群落，以改善其健康、生產力和永續性。隨著人們對更安全蛋白質替代品的需求日益成長，該領域正從傳統抗生素轉向生物療法，益生菌和創新定序技術能夠實現精準干預，並因此備受關注。如今，企業更傾向於使用特定的微生物群落而非頻譜益生菌，改善動物健康並提高農場盈利。人工智慧技術的進步進一步提升了診斷準確性，能夠可靠地檢測相關微生物類群，並揭示微生物組模式與臨床結果之間的關聯。這一發展趨勢正在吸引各領域的投資和合作，推動水產養殖、寵物護理和環保畜牧業實踐取得顯著進展。

全球動物微生物組市場促進因素

隨著生產者積極採用以微生物組為基礎的產品來改善動物健康、最佳化飼料轉換率並增強抗病能力，全球動物微生物組市場需求激增。這種日益成長的興趣正在推動創新，減少對傳統干預措施的依賴，並為客製化益生菌、益生元和診斷技術的投資鋪平道路。隨著農場經營者將永續性和動物福利置於優先地位，各公司正積極拓展產品線和分銷管道，以加速市場進入。動物生產力和產品品質的顯著提升，促使相關人員更願意將微生物組解決方案融入其實踐，從而推動更廣泛的商業性認可和市場逐步成長。

全球動物微生物組市場的限制因素

全球動物微生物組市場面臨許多挑戰，主要源自於區域層面複雜且不斷變化的法規結構。這種監管複雜性導致製造商和開發商在產品分類、功效聲明和核准流程方面存在不確定性，阻礙了市場准入和商業化進程。安全性資料和功效論證要求的差異也使全球產品推廣更加複雜，需要投入更多的時間和資源來確保合規。小規模企業被迫推遲研發計畫並限制其業務範圍，而成熟企業則面臨日益沉重的監管負擔。這種監管上的不確定性最終會減緩生產商和經銷商對產品的接受度，降低投資吸引力，並限制創新微生物組解決方案的上市速度。

動物微生物組市場的全球趨勢

全球動物微生物組市場正日益接受精準微生物組營養。飼料和補充劑開發商正致力於開發基於微生物組的策略，以適應動物獨特的腸道生態系統。這一趨勢推動了原料選擇和添加劑配方向特定微生物功能方向轉變，從而提高飼料轉換率、動物健康和產品品質。此外，市場對包含微生物分析和可操作建議的綜合解決方案的需求也在不斷成長，這使得營養師能夠從通用飼餵方法轉向有針對性的、以結果為導向的方案。這種轉變不僅有利於動物福利和永續性，也代表著畜牧業營養管理向個人化方向邁進的進步。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球動物微生物組市場規模：按動物類型和複合年成長率分類（2026-2033 年）

• 寵物
• 家畜
• 水產養殖

全球動物微生物組市場規模：依產品類型及複合年成長率分類（2026-2033 年）

• 益生菌
• 益生元
• 共生
• 微生物生質能

全球動物微生物組市場規模：按來源和複合年成長率分類（2026-2033 年）

• 植物來源
• 動物源性
• 發酵

全球動物微生物組市場規模：按類型和複合年成長率分類（2026-2033 年）

• 粉末
• 液體
• 顆粒
• 其他

全球動物微生物組市場規模：按應用和複合年成長率分類（2026-2033 年）

• 保持健康
• 疾病治療
• 營養與補充品
• 其他

全球動物微生物組市場規模：依最終用戶和複合年成長率分類（2026-2033 年）

• 家禽養殖戶
• 寵物飼主
• 動物醫院
• 研究機構

全球動物微生物組市場規模：按分銷管道和複合年成長率分類（2026-2033 年）

• 線上零售
• 線下零售

全球動物微生物組市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• AnimalBiome
• ProDigest
• Lallemand
• Adisseo
• Hills Pet Nutrition
• Pando Nutrition
• CanBiocin
• MiDOG
• DNA Genotek
• Animab
• BaseClear
• Novonesis
• MicroSintesis
• Eligo Bioscience
• Eubiotics
• Resistomap
• DSM-Firmenich
• Phileo
• Mootral
• Evonik

結論與建議

Global Animal Microbiome Market size was valued at USD 4.3 Billion in 2024 and is poised to grow from USD 4.69 Billion in 2025 to USD 9.42 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global animal microbiome market focuses on the analysis and manipulation of microbial communities in livestock, aquaculture species, and companion animals to enhance health, productivity, and sustainability. As the demand for safer protein alternatives rises, the sector shifts from traditional antibiotics to biological methods, highlighting probiotics and innovative sequencing techniques that allow for precise interventions. Companies are now prioritizing defined microbial consortia over broad-spectrum probiotics, resulting in improved animal health outcomes that translate into farm profitability. Advances in AI further enhance diagnostic accuracy, enabling reliable detection of relevant microbial taxa and linking microbiome patterns to clinical outcomes. This evolution attracts investment and partnerships across various sectors, fostering significant advancements in aquaculture, pet care, and environmentally conscious livestock practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Microbiome market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Microbiome Market Segments Analysis

Global animal microbiome market is segmented by animal type, product type, source, form, application, end user, distribution channel and region. Based on animal type, the market is segmented into Pets, Livestock and Aquaculture. Based on product type, the market is segmented into Probiotics, Prebiotics, Symbiotic and Microbial Biomass. Based on source, the market is segmented into Plant based, Animal Based and Fermented. Based on form, the market is segmented into Powder, Liquid, Granules and Others. Based on application, the market is segmented into Health Maintenance, Disease Treatment, Nutrition and Supplements and Others. Based on end user, the market is segmented into Poultry Farmers, Pet Owners, Veterinary Clinics and Research Institutions. Based on distribution channel, the market is segmented into Online Retail and Offline Retail. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Microbiome Market

The Global Animal Microbiome market is witnessing a surge in demand as producers worldwide increasingly embrace microbiome-based products to enhance animal health, optimize feed efficiency, and bolster disease resilience. This growing interest stimulates innovation and reduces dependence on traditional interventions, paving the way for investments in customized probiotics, prebiotics, and diagnostics. As farm managers prioritize sustainability and animal welfare, companies are actively broadening their offerings and distribution channels, promoting faster market adoption. The recognized advantages in animal performance and product quality further encourage stakeholders to adopt microbiome solutions in their management practices, leading to wider commercial acceptance and progressive market expansion.

Restraints in the Global Animal Microbiome Market

The global animal microbiome market faces significant challenges due to complex and ever-changing regulatory frameworks present across different regions. These regulatory complexities lead to uncertainty for manufacturers and developers regarding product classification, claims, and approval processes, thereby hindering market entry and commercialization efforts. Disparate requirements for safety data and efficacy demonstrations complicate the global launch of products, demanding more time and resources for compliance. Smaller companies might delay their development initiatives or limit their geographical reach, while established enterprises confront increased regulatory burdens. This ambiguity in regulations ultimately slows down the adoption of products by producers and distributors, diminishes investment appeal, and restricts the speed at which innovative microbiome solutions can be introduced to the market.

Market Trends of the Global Animal Microbiome Market

The Global Animal Microbiome market is increasingly embracing precision microbiome nutrition, where feed and supplement developers are focusing on microbiome-informed strategies tailored to the unique gut ecology of animals. This trend highlights a shift towards aligning ingredient selection and additive profiles with specific microbial functions to enhance feed efficiency, animal health, and product quality. Furthermore, there is a rising demand for integrated solutions that encompass microbial profiling and actionable recommendations, enabling nutritionists to transition from generic feeding approaches to targeted, outcome-driven programs. This evolution not only supports animal welfare and sustainability but also signifies a progressive move towards personalized nutrition in animal husbandry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Animal Microbiome Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Pets
• Livestock
• Aquaculture

Global Animal Microbiome Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Probiotics
• Prebiotics
• Symbiotic
• Microbial Biomass

Global Animal Microbiome Market Size by Source & CAGR (2026-2033)

• Market Overview
• Plant based
• Animal Based
• Fermented

Global Animal Microbiome Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Liquid
• Granules
• Others

Global Animal Microbiome Market Size by Application & CAGR (2026-2033)

• Market Overview
• Health Maintenance
• Disease Treatment
• Nutrition and Supplements
• Others

Global Animal Microbiome Market Size by End User & CAGR (2026-2033)

• Market Overview
• Poultry Farmers
• Pet Owners
• Veterinary Clinics
• Research Institutions

Global Animal Microbiome Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Online Retail
• Offline Retail

Global Animal Microbiome Market Size & CAGR (2026-2033)

• North America (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • US
  • Canada
• Europe (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Animal Type, Product Type, Source, Form, Application, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AnimalBiome
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProDigest
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adisseo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hills Pet Nutrition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pando Nutrition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CanBiocin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiDOG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Genotek
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animab
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BaseClear
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novonesis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroSintesis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eligo Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eubiotics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Resistomap
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM-Firmenich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phileo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mootral
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations